Re: Treatment duration of enterococcal intravascular catheter-related infections-authors' reply
Clin Microbiol Infect
.
2021 Mar;27(3):493.
doi: 10.1016/j.cmi.2020.11.034.
Epub 2020 Dec 16.
Authors
Elena Rosselli Del Turco
1
,
Michele Bartoletti
1
,
Anders Dahl
2
,
Carlos Cervera
3
,
Juan M Pericàs
4
Affiliations
1
Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
2
Department of Cardiology Herlev-Gentofte University Hospital, Copenhagen, Denmark.
3
Division of Infectious Diseases, University of Alberta, Edmonton, Canada.
4
Infectious Diseases Department, Hospital Clínic de Barcelona, Barcelona, Spain; Vall d'Hebron Institute for Research (VHIR), Barcelona, Spain. Electronic address: jpericas@clinic.cat.
PMID:
33340670
DOI:
10.1016/j.cmi.2020.11.034
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Catheter-Related Infections* / drug therapy
Duration of Therapy
Enterococcus
Humans
Substances
Anti-Bacterial Agents